两例GCK基因突变家系的分子遗传学分析及临床思考

基础医学与临床 ›› 2020, Vol. 40 ›› Issue (12): 1640-1644.

两例GCK基因突变家系的分子遗传学分析及临床思考

王志新, 左庆瑶, 李伟, 陈佳, 邓微^*

北京积水潭医院北京大学第四临床医学院内分泌科, 北京 100035

收稿日期:2020-03-29 修回日期:2020-08-26 出版日期:2020-12-05 发布日期:2020-11-30
通讯作者: ^* dengwei95 @163.com
基金资助:
北京市优秀人才培养(2017000021469G260)

Molecular genetic analysis and clinical consideration of two families with GCK gene mutation

WANG Zhi-xin, ZUO Qing-yao, LI Wei, CHEN Jia, DENG Wei^*

Department of Endocrinology, Beijing Jishuitan Hospital, 4th Medical College of Peking University, Beijing 100035, China

Received:2020-03-29 Revised:2020-08-26 Online:2020-12-05 Published:2020-11-30
Contact: ^* dengwei95 @163.com

摘要/Abstract

摘要： 目的探讨2例葡萄糖激酶基因(GCK,NM_000162.4、NP_ 000153.1)突变导致的青少年的成人发病型糖尿病(MODY)患者的分子遗传学及临床特征。方法收集2015年4月至2015年12月北京积水潭医院收治并疑诊为MODY的2例患者的临床资料并进行分析,对该2例患者及其家系成员进行GCK基因测序,分析致病原因。结果在2例家系中,发现1个新的GCK基因杂合突变p.T82P(c.244 A＞C)和1个已报告的GCK基因杂合突变p.V412M(c.1234G＞A)。在临床表现方面,在2个家系的3例GCK基因突变携带者中,除血糖升高外,尚有不同程度的代谢综合征的临床表现。结论 GCK基因T82P突变可能是MODY2的致病原因。GCK基因突变携带者临床表现复杂,在治疗和预后判断上需要个体化。

关键词: 青少年的成人发病型糖尿病, 葡萄糖激酶, 基因突变

Abstract: Objective To explore the molecular genetics and clinical characteristics of two cases of maturity-onset diabetes of the young (MODY) type 2 caused by glucokinase (GCK) gene mutation. Methods Two patients who were admitted into Beijing Jishuitan Hospital with suspected diagnosis of MODY from April 2015 to December 2015 were collected and analyzed by their clinical data. GCK gene sequencing was carried out for the two patients and their family members to find the cause of their disease. Results A new GCK heterozygous mutation p.T82P (c.244 A ＞ C) and a reported GCK heterozygous mutation p.V412M (c.1234 G ＞ A) were found in the two families. In the aspect of clinical manifestations, in addition to stable hyperglycemia, the 3 GCK gene mutation carriers in the two families showed metabolic syndrome of varying degrees. Conclusions GCK gene mutation p.T82P may be the cause of MODY2. The clinical manifestations of GCK gene mutation carriers are complex, and they need to be individualized and managed in treatment and prognosis.

Key words: maturity-onset diabetes of the young, glucokinase, gene mutation

中图分类号:

王志新, 左庆瑶, 李伟, 陈佳, 邓微. 两例GCK基因突变家系的分子遗传学分析及临床思考[J]. 基础医学与临床, 2020, 40(12): 1640-1644.

WANG Zhi-xin, ZUO Qing-yao, LI Wei, CHEN Jia, DENG Wei. Molecular genetic analysis and clinical consideration of two families with GCK gene mutation[J]. Basic & Clinical Medicine, 2020, 40(12): 1640-1644.

参考文献

[1] Wang Z, Ping F, Zhang Q, et al. Preliminary screening of mutations in the glucokinase gene of Chinese patients with gestational diabetes[J]. J Diabetes Invest, 2018, 9: 199-203.
[2] 王志新,平凡,张茜,等. 中国妊娠期血糖异常人群葡萄糖激酶基因突变初步筛查[J]. 中华糖尿病杂志, 2014, 6: 397-401.
[3] Osbak K, Colclough K, Saint-Martin C, et al. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia[J]. Hum Mutat, 2009, 30: 1512-1526.
[4] Marotta D, Anand G, Anderson T, et al. Identification and characterization of the ATP-binding site in human pancreatic glucokinase[J]. Arch Biochem Biophys, 2005, 436: 23-31.
[5] Marks S, Couch R. Identification of two new mutations in the glucokinase gene that result in maturity-onset diabetes of the young[J]. Diabetes Care, 2010, 33: e94. doi: 10.2337/dc10-0685.
[6] Estalella I, Rica I, Perez De Nanclares G, et al. Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain[J]. Clin Endocrinol (Oxf), 2007, 67: 538. doi: 10.1111/j.1365-2265.2007.02921.x.
[7] 王志新,于淼,郑佳,等. 四例中国青少年的成人起病型糖尿病2型家系的临床与分子遗传学研究[J]. 中华糖尿病杂志, 2014, 6: 21-26.
[8] Wang Z, Diao C, Liu Y, et al. Identification and functional analysis of GCK gene mutations in 12 Chinese families with hyperglycemia[J]. J Diabetes Invest, 2019, 10: 963-971.
[9] Thanabalasingham G, Owen K. Diagnosis and manage-ment of maturity onset diabetes of the young (MODY)[J]. BMJ, 2011, 343: d6044. doi: 10.1136/bmj.d6044.
[10] Stride A, Vaxillaire M, Tuomi T, et al. The genetic abnormality in the beta cell determines the response to an oral glucose load[J]. Diabetologia, 2002, 45: 427-435.
[11] Stoffel M, Bell K, Blackburn C, et al. Identification of glucokinase mutations in subjects with gestational diabetes mellitus[J]. Diabetes, 1993, 42: 937-940.
[12] Ellard S, Bellanne-Chantelot C, Hattersley A. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young[J]. Diabetologia, 2008, 51: 546-553.
[13] Steele A, Shields B, Wensley K, et al. Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia[J]. JAMA, 2014, 311: 279-286.
[14] Fendler W, Malachowska B, Baranowska-Jazwiecka A, et al. Population-based estimates for double diabetes amongst people with glucokinase monogenic diabetes, GCK-MODY[J]. Diabet Med, 2014, 31: 881-883.
[15] Liu L, Liu Y, Ge X, et al. Insights into pathogenesis of five novel GCK mutations identified in Chinese MODY patients[J]. Metabolism, 2018, 89: 8-17.
[16] Martin D, Bellanne-Chantelot C, Deschamps I, et al. Long-term follow-up of oral glucose tolerance test-derived glucose tolerance and insulin secretion and insulin sensitivity indexes in subjects with glucokinase mutations (MODY2)[J]. Diabetes Care, 2008, 31: 1321-1323.
[17] Spegel P, Ekholm E, Tuomi T, et al. Metabolite profiling reveals normal metabolic control in carriers of mutations in the glucokinase gene (MODY2)[J]. Diabetes, 2013, 62: 653-661.